<DOC>
	<DOCNO>NCT01345227</DOCNO>
	<brief_summary>The goal study evaluate safety feasibility bone marrow ( BM ) site islet transplantation ( Tx ) human . The investigator hypothesis BM represent well site liver thanks potential capacity favor islet engraftment face easiness access bioptic follow .</brief_summary>
	<brief_title>Bone Marrow Alternative Site Islet Transplantation</brief_title>
	<detailed_description>We permit perform single intra BM islet infusion level iliac crest patient contraindication intraportal infusion . A needle BM aspiration ( 14 G ) insert superior-posterior iliac crest islet suspension ( 1:2.5 ; tissue : Ringer 's Lactate solution ) infuse . The entire intraBM-injection procedure last 8-15 min begin anaesthesia ( short propofol sedation ) .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>diabetic patient eligible pancreatic islet transplantation base local accepted practice guideline . This include least : ) clinical history compatible T1D insulindependence &gt; 5 year ; b ) undetectable stimulate ( arginine MMTT ) Cpeptide level ( &lt; 0.3 ng/mL ) 12 month transplant c ) presence severe hypoglycaemic event patient undergo total pancreatectomy anastomosis leakage pancreatoduodenectomy pancreatic anastomosis make impracticable technical difficulty and/or high risk leakage . presence contraindication intraportal islet infusion presence hematologic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>islet transplantation</keyword>
	<keyword>autotransplantation</keyword>
</DOC>